Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study. [electronic resource]
Producer: 20140307Description: 951-8 p. digitalISSN:- 1502-7708
- Abortion, Spontaneous -- chemically induced
- Adalimumab
- Adult
- Anti-Inflammatory Agents -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Birth Weight
- Drug Administration Schedule
- Enzyme-Linked Immunosorbent Assay
- Female
- Fetal Blood -- metabolism
- Humans
- Infant, Newborn
- Inflammatory Bowel Diseases -- blood
- Infliximab
- Pregnancy
- Pregnancy Complications -- blood
- Pregnancy Outcome
- Premature Birth -- chemically induced
- Prenatal Care
- Prenatal Exposure Delayed Effects -- chemically induced
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.